Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van de Ven, M. J. T.
Right arrow Articles by Folgering, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van de Ven, M. J. T.
Right arrow Articles by Folgering, H.
(Chest. 2002;121:383-392.)
© 2002 American College of Chest Physicians

Effects of Acetazolamide and Furosemide on Ventilation and Cerebral Blood Volume in Normocapnic and Hypercapnic Patients With COPD*

Marjo J. T. van de Ven, MD; Willy N. J. M. Colier, PhD; Marco C. van der Sluijs, BSc; Berend Oeseburg, MD, PhD; Piet Vis, MD, PhD and Hans Folgering, MD, PhD

* From the Department of Pulmonology Dekkerswald (Drs. van de Ven and Folgering) and the Department of Physiology (Drs. Colier, Oeseburg, and Vis and Mr. van der Sluijs), Faculty of Medical Sciences, University Medical Center Nijmegen, The Netherlands.

Correspondence to: Marjo J. T. van de Ven, MD, Department of Pulmonology Dekkerswald, University Medical Center Nijmegen, PO Box 9001, 6560 GB Groesbeek, The Netherlands; e-mail: m_vandeven60{at}hotmail.com

Study objectives: Effects of chronic metabolic alkalosis and acidosis and their relation to central chemoregulation may differ between normocapnic and chronic hypercapnic patients with COPD. The relationship between responses of inspired ventilation (VI), mouth occlusion pressure (P0.1), and cerebral blood volume (CBV), to short-term changes in arterial PCO2 was measured.

Patients and methods: Seventeen patients with chronic hypercapnia and COPD (PaCO2 > 6.0 kPa) and 16 normocapnic patients with COPD (PaCO2 <= 6.0 kPa) [FEV1 27% predicted] were studied under baseline metabolic conditions and after 1 week of treatment with oral furosemide, 40 mg/d, or acetazolamide, 500 mg/d. Hypercapnia (change in end-tidal carbon dioxide > 1 kPa) was induced by administering adequate amounts of carbon dioxide in the inspired air. CBV was measured using near-infrared spectroscopy.

Results: Compared with baseline metabolic condition, chronic metabolic acidosis and alkalosis did not change ventilatory ({Delta}VI/{Delta}PaCO2) and cerebrovascular ({Delta}CBV/{Delta}PaCO2) reactivity. Base excess (BE) decreased by 6.8 ± 1.1 mEq/L and 6.9 ± 1.6 mEq/L, respectively, in the normocapnic and chronic hypercapnic COPD groups during metabolic acidosis, resulting in a not-quite-significant leftward shift of both the ventilatory and cerebrovascular carbon dioxide response curve. BE increased by 2.3 ± 1.2 mEq/L and 1.2 ± 1.3 mEq/L, respectively, during chronic metabolic alkalosis in both COPD groups, without concomitant shift. Poor correlations between ventilatory and cerebrovascular carbon dioxide responsiveness ({Delta}CBV/{Delta}PaCO2 and {Delta}VI/{Delta}PaCO2, {Delta}CBV/{Delta}PaCO2 and {Delta}P0.1/{Delta}PaCO2, respectively) were found irrespective of baseline, respiratory condition, and induced metabolic state.

Conclusions: Normocapnic and chronic hypercapnic COPD patients have the same ventilatory and cerebrovascular carbon dioxide responsiveness irrespective of induced metabolic state.

Key Words: acid-base • central chemosensitivity • cerebral blood volume • control of breathing • COPD • metabolic acidosis • metabolic alkalosis • mouth occlusion pressure • near-infrared spectroscopy






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American College of Chest Physicians.